A medium-term management plan has been formulated for the five fiscal years from the fiscal year ending August 2027 to the fiscal year ending August 2031. Targeting consolidated net sales of 45,440 hundred million yen in the final year, the company will strengthen domestic and overseas businesses (OEM\/overseas business\/e-commerce\/pharmaceuticals\/real estate & tourism, etc.). Specific strategies and sales targets are set for each segment.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"2927","jir_company_name":"AFC-HD AMS Life Science Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-10-16","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/10\/2927-20261016-01.pdf","jir_short_summary":"A medium-term management plan has been formulated for the five fiscal years from the fiscal year ending August 2027 to the fiscal year ending August 2031. Targeting consolidated net sales of 45,440 hundred million yen in the final year, the company will strengthen domestic and overseas businesses (OEM\/overseas business\/e-commerce\/pharmaceuticals\/real estate & tourism, etc.). Specific strategies and sales targets are set for each segment.","jir_summary":"### Formulation and Overview of the Medium-Term Management Plan\nAFC-HD AMS Life Science Co., Ltd. has formulated a medium-term management plan covering the five years from the fiscal year ending August 2027 through the fiscal year ending August 2031. The plan aims to strengthen the foundation in the health foods and pharmaceuticals fields and promote diversification such as overseas expansion, e-commerce, real estate, and tourism, with the goal of achieving sustained growth in profitability and corporate value across each business.\n\n### Key Initiatives and Segment-Specific Strategies\nIn the OEM business, development competitiveness will be enhanced by leveraging quality control and responses to functional food notifications. In overseas businesses, new markets will be developed through halal certification and utilization of local personnel. The e-commerce business will focus on improving retention rates, increasing regular subscription customers, and expanding EC. The pharmaceutical business will strengthen dual-axis proposals and stable supply systems. Other businesses including department stores, real estate, tourism, education, and catering will promote new brands and internal organizational optimization.","jir_financial_highlights":"Consolidated Net Sales: Unknown (Unknown)\nFinal Year Net Sales Target: 45,440 hundred million yen (Planned value)","jir_category":"","jir_hashtags":"#AFC-HD_AMS_Life_Science, #MediumTermManagementPlan, #SegmentStrategy","jir_key_figures":"Final Year Net Sales Target: 45,440 hundred million yen\nPast Consolidated Net Sales Figures: Unknown\nSales targets for each segment are set by fiscal year (e.g., OEM, Overseas, E-commerce, Pharmaceuticals, etc.)","jir_meta_title":"AFC-HD AMS Life Science Co., Ltd. - Notice of Formulation of Medium-Term Management Plan | October 16, 2026","jir_meta_description":"AFC-HD AMS Life Science Co., Ltd. announces a medium-term management plan. Over the five-year period 2027\u20132031, the company targets net sales of 45,440 hundred million yen and will pursue diversification across OEM, overseas, e-commerce, pharmaceuticals, real estate, and tourism. Key points for investors summarized.","jir_og_title":"AFC-HD AMS Life Science Co., Ltd. - Notice of Formulation of Medium-Term Management Plan","jir_og_description":"The five-year medium-term plan targets net sales of 45,440 hundred million yen and outlines diversification strategies across OEM, overseas, e-commerce, pharmaceuticals, real estate, and tourism. Investor highlights summarized.","jir_og_image_url":"\/assets\/og\/company-business_update.jpg","jir_chart_data_collection":"[]","ir_related_company":58627,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"business_update","footnotes":""},"sector":[],"importance":[],"class_list":["post-132007","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n